Guangdong Lifestrong Pharmacy Co., Ltd. Class A

Guangdong Lifestrong Pharmacy Co., Ltd. Class A

SSZSE:301111
16.07
CNY
-0.41
(-2.49%)
0.02EPS
512.76P/E
3.41BMarket Cap
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.6
2.42
2.66
2.84
2.94
1.78
1.83
2.01
2.1
1.87
Basic EPS, GAAP
0.27
0.53
0.56
0.52
0.48
0.21
0.21
0.03
-0.03
0.04
Free Cash Flow per Basic Share
0.04
0.33
0.3
0.37
0.58
0.4
-0.32
-0.25
0.01
- -
Dividend per Share
0.4
0.01
0.25
0.09
- -
0.16
0.1
0.12
0.05
- -
Book Value per Share
1.39
1.92
2.26
2.7
4.69
4.74
4.85
4.78
4.69
4.66
Tangible Book Value per Share
1.31
1.84
2.19
2.63
4.64
4.69
4.66
4.54
4.46
4.43
Basic Weighted Avg Shares
120
120
119
120
119
159
160
139
150
160
Sales/Revenue/Turnover
192
290
317
341
350
283
292
279
315
299
Operating Margin (%)
20.79
26.05
100
21.31
18.84
9.51
9.93
-1.77
-5.74
-0.38
Depreciation Expense
10
8
18
11
15
12
13
18
18
- -
Net Income, GAAP
33
64
67
63
57
33
34
4
-4
7
Effective Tax Rate (%)
14.61
14.5
16.89
13.72
14.3
3.83
12.76
- -
- -
58.7
Profit Margin (%)
17.1
21.89
21.05
18.34
16.35
11.79
11.46
1.49
-1.43
2.23
Working Capital
95
162
205
235
643
508
444
420
599
632
LT Debt
- -
- -
- -
- -
- -
- -
10
71
40
36
Total Equity
166
230
272
323
751
759
778
767
751
776
Return on Invested Capital (%)
- -
28.85
28.64
21.72
11.24
5.42
4.59
- -
- -
- -
Return on Capital (%)
- -
30.32
26.57
21.01
10.64
4.43
4.49
- -
- -
- -
Return on Common Equity (%)
- -
32.1
26.57
21.01
10.65
4.43
4.37
0.54
-0.59
- -

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
6
7
6
LT Borrowings
- -
- -
- -
LT Finance Leases
39
36
36
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
160
160
160
Market Capitalization
3,024
4,141
3,408

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
697
725
736
Cash, Cash Equivalents & STI
202
435
388
Accounts Receivable, Net
83
94
97
Inventories
76
76
89
Total Current Liabilities
108
116
104
Payables & Accruals
- -
- -
- -
ST Debt
6
7
6
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
26.46%
-2.03%
Free Cash Flow
- -
-53.58%
-102.32%
Net Income, GAAP
- -
-69.05%
-207.83%
Sales/Revenue/Turnover
- -
-1%
12.92%
Total Cash Common Dividend
- -
- -
-50%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
71
81
76
50
279
2025
71
84
- -
86
315
2026
66
79
68
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.07
0.02
-0.01
-0.06
0.03
2025
-0.02
-0.02
- -
0.02
-0.03
2026
-0.02
0.04
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.12
2025
- -
- -
- -
- -
0.05
2026
- -
- -
- -
- -
- -

Company Description

CEO
Xian Tao Ou
Full Time Employees
578
Sector
Health technology
Industry
Pharmaceuticals: major
Address
No. 08, Block 16th Shantou GD China 515064
IPO Date
Dec 7, 2021
Business
Guangdong Lifestrong Pharmacy Co., Ltd. is actively involved in the comprehensive cycle of pharmaceutical operations, encompassing the research, development, manufacturing, and distribution of its diverse range of medicinal products. The company produces various pharmaceutical forms, including tablets, capsules, injections, mixtures, and granules. Its extensive product portfolio addresses multiple therapeutic needs, spanning respiratory conditions, pediatric health, gynecological care, urinary system issues, and general nutrition and wellness. With a heritage dating back to 1891 and officially established in 1951, the firm stands as a recognized "old Chinese brand" that merges traditional medicinal practices with contemporary pharmaceutical technology. The company maintains its headquarters in Shantou, China.